E047: Dina Burkitbayeva: PsyMed Ventures

PsyMed Ventures is a $25m venture fund focused on cutting edge mental health treatments including psychedelic therapeutic, neurotechnology, precision psychiatry and digital therapeutics. PsyMed Ventures invests in pre-seed, seed and Series A round. A third of PsyMed's current portfolio companies are co-founded by female founders. PsyMed donates 4.19% (wink to Bicycle Day, the day LSD was invested) to indigenous communities and non-profits in psychedelics space.

Show Notes

Chapters:

00:00 Introduction
00:16 What inspired you to become a VC?
01:43 What is your investment thesis? What is the motivation for your thesis?
05:21 What are you currently reading or learning or listening to these days?
06:22 In 2 years, how do you see venture capital evolved or changed?
08:21 How do people contact you?
08:45 Thank you

Featured Guest Bio:

Dina Burkitbayeva is a co-founder and general partner at PsyMed Ventures, venture fund focused on cutting edge mental health treatments including psychedelic therapeutic, neurotechnology, precision psychiatry and digital therapeutics. Dina is also the co-founder and CEO of Freedom Biosciences, clinical stage biotech company developing next generation ketamine and psychedelic therapeutics. Dina holds an MBA from Harvard Business School and is working towards her MA in East West Psychology with focus on psychedelic therapy at California Institute of Integral Studies. Dina lives in San Francisco, CA.

Fund Information:

Fund Site:

www.psymed.ventures

Fund Contact:

https://www.linkedin.com/company/psymed-ventures/?viewAsMember=true

@psymedventures

Featured Episodes

Here are some great episodes to start with.